Biora Therapeutics (BIOR) Misses Q3 EPS by 504c

Biora Therapeutics (NASDAQ: BIOR) reported Q3 EPS of ($5.04). Revenue for the quarter came in at $30 thousand.

For earnings history and earnings-related data on Biora Therapeutics (BIOR) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Kite Realty Group Trust files for 12M share offering by selling stockholders
• HF Foods ends $100M at-the-market stock offering program